Quick Answer
Jade Biosciences, Inc. reported Net Income of -$127.41 million for fiscal year 2025.
Jade Biosciences, Inc. Net Income — Annual History
| Fiscal Year | Net Income | YoY Change |
|---|---|---|
| 2025 | -$127.41M | -83.0% |
| 2024 | -$69.63M | +7.8% |
| 2023 | -$75.52M | -46.6% |
| 2022 | -$51.51M | -124.3% |
| 2021 | -$22.96M | -138.9% |
| 2020 | -$9.61M | — |
Quarterly Net Income
| Quarter Ending | Net Income | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | -$25.18M | -54.7% | +21.7% |
| June 30, 2025 | -$32.13M | -5346.4% | +15.8% |
| March 31, 2025 | -$38.17M | -64.6% | -134.5% |
| September 30, 2024 | -$16.28M | +16.8% | -2658.8% |
| June 30, 2024 | -$590.0K | +96.9% | +97.5% |
| March 31, 2024 | -$23.19M | -40.4% | -18.5% |
| September 30, 2023 | -$19.56M | -44.0% | -2.8% |
| June 30, 2023 | -$19.02M | -58.7% | -15.2% |
- Jade Biosciences, Inc. showed a decrease of -83.0% in Net Income compared to the prior fiscal year.
- Over the 2020–2025 period, Jade Biosciences, Inc.’s net income has declined by 1225.7% (from -$9.61 million to -$127.41 million).
- The most recent figure is from Jade Biosciences, Inc.’s fiscal year 2025 report (Form 10-K), filed with the SEC on March 6, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: